Florida / New York
Droplet IV today announced the successful completion of a $2 million funding round to enable launch of its first automatic IV-line flushing device in the
The round welcomed new funds GLIN Impact Capital, Wealthing VC Club, and Citrine Angels, and was led by InnovaHealth Partners and other key existing investors.
This significant funding will fuel the continued expansion of Glytec’s platform, including its flagship Glucommander® SaaS solution, accelerate the development of innovative new technologies to address the growing global health crisis of diabetes and related co-morbidities, and support the continued rapid response to upcoming CMS quality measures that will hold health systems accountable for inpatient glycemic control.
Devyser is today announcing that the company’s clinical testing laboratory in Roswell in Atlanta, Georgia, has received CLIA certification. This certification allows the Devyser US lab to begin testing on patient samples.
The Certificate of Registration has been issued to the Devyser laboratory by the Centers for Medicare and Medicaid Services (CMS) under the Clinical Laboratory Improvement Amendments (CLIA).
“The CLIA certification is very important for us, and we are proud that our new CLIA lab will give access to patients and their physicians to novel laboratory developed tests,” says Fredrik Alpsten, CEO at Devyser.
Certification of the Devyser lab under CLIA enables highly useful testing for hereditary diseases, oncology, and post-transplant follow-up. The Devyser lab will offer test services directly to US physicians. The physicians will send test samples to the lab that will run the tests and provide the physicians with test results that can be used to manage patients.
The information was submitted for publication, through the agency of the contact persons below, on May 8, 2023, at 07:00 CET.
Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved
Hours:
M – F 8 am – 5 pm
Florida / New York
Phone: 561.316.3330